Release of a disordered domain enhances HspB1 chaperone activity toward tau.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
11 02 2020
Historique:
pubmed: 25 1 2020
medline: 28 5 2020
entrez: 25 1 2020
Statut: ppublish

Résumé

Small heat shock proteins (sHSPs) are a class of ATP-independent molecular chaperones that play vital roles in maintaining protein solubility and preventing aberrant protein aggregation. They form highly dynamic, polydisperse oligomeric ensembles and contain long intrinsically disordered regions. Experimental challenges posed by these properties have greatly impeded our understanding of sHSP structure and mechanism of action. Here we characterize interactions between the human sHSP HspB1 (Hsp27) and microtubule-associated protein tau, which is implicated in multiple dementias, including Alzheimer's disease. We show that tau binds both to a well-known binding groove within the structured alpha-crystallin domain (ACD) and to sites within the enigmatic, disordered N-terminal region (NTR) of HspB1. However, only interactions involving the NTR lead to productive chaperone activity, whereas ACD binding is uncorrelated with chaperone function. The tau-binding groove in the ACD also binds short hydrophobic regions within HspB1 itself, and HspB1 mutations that disrupt these intrinsic ACD-NTR interactions greatly enhance chaperone activity toward tau. This leads to a mechanism in which the release of the disordered NTR from a binding groove on the ACD enhances chaperone activity toward tau. The study advances understanding of the mechanisms by which sHSPs achieve their chaperone activity against amyloid-forming clients and how cells defend against pathological tau aggregation. Furthermore, the resulting mechanistic model points to ways in which sHSP chaperone activity may be increased, either by native factors within the cell or by therapeutic intervention.

Identifiants

pubmed: 31974309
pii: 1915099117
doi: 10.1073/pnas.1915099117
pmc: PMC7022203
doi:

Substances chimiques

HSPB1 protein, human 0
Heat-Shock Proteins 0
Molecular Chaperones 0
alpha-Crystallins 0
tau Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2923-2929

Subventions

Organisme : NEI NIH HHS
ID : R01 EY017370
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008268
Pays : United States

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

Biochemistry. 2012 Jun 26;51(25):5105-12
pubmed: 22670769
Nature. 2017 Jul 13;547(7662):185-190
pubmed: 28678775
Nat Struct Mol Biol. 2018 May;25(5):384-393
pubmed: 29728653
J Biol Chem. 2018 Sep 21;293(38):14880-14890
pubmed: 30076220
Elife. 2015 May 11;4:
pubmed: 25962097
Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6409-14
pubmed: 21464278
J Biol Chem. 2004 Apr 23;279(17):17957-62
pubmed: 14963027
J Biol Chem. 1999 Jul 2;274(27):18947-56
pubmed: 10383393
J Biol Chem. 2009 Jul 10;284(28):18801-7
pubmed: 19411251
Cell Stress Chaperones. 2017 Jul;22(4):569-575
pubmed: 28332148
Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):E3780-9
pubmed: 24043785
J Struct Biol. 2014 Mar;185(3):342-54
pubmed: 24382496
Nat Commun. 2018 Nov 1;9(1):4563
pubmed: 30385828
Cold Spring Harb Perspect Biol. 2019 Oct 1;11(10):
pubmed: 30833458
Structure. 2018 Aug 7;26(8):1116-1126.e4
pubmed: 29983375
Proc Natl Acad Sci U S A. 2014 Apr 22;111(16):E1562-70
pubmed: 24711386
J Biomol NMR. 2015 Oct;63(2):223-8
pubmed: 26243512
J Mol Biol. 2018 Sep 14;430(18 Pt B):3297-3310
pubmed: 29969581
Chem Biol. 2015 Feb 19;22(2):186-95
pubmed: 25699602
EMBO J. 2012 Dec 12;31(24):4587-94
pubmed: 23188086
J Mol Biol. 2011 Oct 21;413(2):310-20
pubmed: 21839749
Nat Struct Mol Biol. 2015 Nov;22(11):898-905
pubmed: 26458046
Science. 1991 Feb 8;251(4994):675-8
pubmed: 1899488
Sci Adv. 2019 May 22;5(5):eaav8421
pubmed: 31131323
Elife. 2019 Oct 01;8:
pubmed: 31573509
Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20491-6
pubmed: 22143763
Structure. 2017 Feb 7;25(2):305-316
pubmed: 28089448
J Mol Biol. 2017 Jan 6;429(1):128-141
pubmed: 27884606
J Neurosci. 2010 Nov 17;30(46):15374-82
pubmed: 21084594
J Biol Chem. 2018 Feb 23;293(8):2687-2700
pubmed: 29298892

Auteurs

Hannah E R Baughman (HER)

Department of Biochemistry, School of Medicine, University of Washington, Seattle, WA 98195.
Department of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, WA 98195.

Thanh-Hau T Pham (TT)

Department of Biochemistry, School of Medicine, University of Washington, Seattle, WA 98195.
Department of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, WA 98195.

Chloe S Adams (CS)

Department of Biochemistry, School of Medicine, University of Washington, Seattle, WA 98195.

Abhinav Nath (A)

Department of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, WA 98195 anath@uw.edu klevit@uw.edu.

Rachel E Klevit (RE)

Department of Biochemistry, School of Medicine, University of Washington, Seattle, WA 98195; anath@uw.edu klevit@uw.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH